Drug intelligence / Profile preview

CD34+ stem cell boost

Development stage
Preclinical
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

A CD34+ stem cell boost is a therapeutic cell therapy procedure involving the infusion of additional hematopoietic stem cells (HSCs) into a patient who has previously undergone an allogeneic hematopoietic cell transplant (HCT) but is experiencing poor graft function or graft failure. The cells are typically enriched for the CD34+ surface marker, which identifies hematopoietic progenitor cells. This boost is often administered without prior conditioning (chemotherapy or radiation), a strategy known as an unconditioned boost, to enhance donor chimerism and improve blood counts without the toxicity associated with a full second transplant. It is primarily utilized as a salvage option in the context of hematologic disorders such as sickle cell disease or following HCT for various malignancies.

Other names
CD34 boostCD-34 boostCD 34 boosthematopoietic stem cell boostHSC boostunconditioned CD34+ boost
02

Targets

SELE (E-selectin)SELL (L-selectin)SELP (P-selectin)VEGFR2 (Vascular endothelial growth factor receptor 2)

Beyond the preview

Go deeper on CD34+ stem cell boost.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD34+ stem cell boost.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call